Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piret Viiklepp

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Statistical Methods in Medical Research|December 14, 2021
Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysisYan Liu, Mireille E Schnitzer, Guanbo Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2026
Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023Thijs Feuth, Iiris Rajalahti, Mikko Vauhkonen, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 22, 2023
National lung cancer screening program feasibility study in EstoniaKadi Kallavus, Kaja-Triin Laisaar, Anneli Rätsep, et al.
Plos One|November 13, 2015
Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional StudyHelen R Stagg, James Brown, Elmira Ibraim, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2017
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not CureMartin J Dedicoat, Gunar Günther, Valeriu Crudu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2022
Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-AnalysisJonathon R Campbell, Edward D Chan, Dennis Falzon, et al.
Tuberculosis (Edinburgh, Scotland)|July 14, 2012
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projectsEkaterina V Kurbatova, Allison Taylor, Victoria M Gammino, et al.
Thorax|December 22, 2023
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysisJonathon R Campbell, Sarah K Brode, Pennan Barry, et al.
Lancet (London, England)|August 11, 2020
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysisGregory P Bisson, Mayara Bastos, Jonathon R Campbell, et al.
American Journal of Respiratory and Critical Care Medicine|March 7, 2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European CountriesGunar Günther, Frank van Leth, Sofia Alexandru, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Statistical Methods in Medical Research|December 14, 2021
Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysisYan Liu, Mireille E Schnitzer, Guanbo Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2026
Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023Thijs Feuth, Iiris Rajalahti, Mikko Vauhkonen, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 22, 2023
National lung cancer screening program feasibility study in EstoniaKadi Kallavus, Kaja-Triin Laisaar, Anneli Rätsep, et al.
Plos One|November 13, 2015
Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional StudyHelen R Stagg, James Brown, Elmira Ibraim, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2017
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not CureMartin J Dedicoat, Gunar Günther, Valeriu Crudu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2022
Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-AnalysisJonathon R Campbell, Edward D Chan, Dennis Falzon, et al.
Tuberculosis (Edinburgh, Scotland)|July 14, 2012
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projectsEkaterina V Kurbatova, Allison Taylor, Victoria M Gammino, et al.
Thorax|December 22, 2023
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysisJonathon R Campbell, Sarah K Brode, Pennan Barry, et al.
Lancet (London, England)|August 11, 2020
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysisGregory P Bisson, Mayara Bastos, Jonathon R Campbell, et al.
American Journal of Respiratory and Critical Care Medicine|March 7, 2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European CountriesGunar Günther, Frank van Leth, Sofia Alexandru, et al.
Pageof 4